Thromboembolic Prophylaxis
Patients in sinus rhythm received dipyridamole and aspirin for the first 3 postoperative months (n=101). Those patients on atrial fibrillation received coumadin for 3 months (n=182) and permanently when a giant left atrium or massive thrombus was found (n=33).
Follow-up
All surviving patients received 3-and 6-month follow-up after surgery and then annual follow-up until the end of the follow-up in December 1991. The follow-up data were procured in a 6-month period (June through December 1991). The patients were followed directly in our outpatient clinic (n= 175) or through direct contact with their cardiologists (n= 130). Results Hospital mortality occurred in 11 patients (3.36%). The cause of death was heart failure in 8 patients, respiratory insufficiency in 2, and hemorrhage in 1. Thirty-one patients (9.5%) presented with postoperative cardiac failure requiring some type of pharmacologic or mechanical support. Hospital mortality for the 226 patients undergoing isolated mitral surgery was 2.7% (6 of 226), and it was 4.9% (5 of 101) (P=.06) for patients with mitrotricuspid surgery.
Postoperative complications immediately after surgery consisted of bleeding requiring reexploration in 9 patients (2.7%) and perioperative major arrhythmias in 7 patients (2.1%).
Of the 316 surviving patients, 42 (Fig 3A) . Hazard function for mitral structural deterioration is shown in Fig 3B. Thromboembolism Thirty-eight thromboembolic events occurred in this series, 12 peripheral and 26 central (15 transient, 10 with permanent neurologic impairment, and 1 patient died). The actuarial curve free from thromboembolism at 16 years is 79.2+3.2% (Fig 4A) . The hazard function for thromboembolism is shown in Fig 4B. One hundred twenty-seven patients with high thromboembolic risk factors (giant left atrium, left atrial thrombosis, and previous thromboembolic event) suf 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 2 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Thromboembolism represents the main complication after surgery. Thirty-eight patients suffered from a thromboembolism episode throughout follow-up (11.6%). The thromboembolic hazard curve shows that the incidence of this complication was higher 10 years after surgery, coinciding with the reoperation hazard curve. The postoperative thromboembolism is related to the etiology of the valve lesion, the existence of preoperative risk factors, and the use of thromboembolic prophylaxis. 43 Patients with rheumatic disease have a higher incidence of thromboembolism than do those with degenerative or ischemic pathology. Longterm studies in patients undergoing isolated open mitral commissurotomy show actuarial curves free from thromboembolism similar to that of our study.36 In our series, it can be noticed that the presence of preoperative risk factors was high (75%). The actuarial curve free from thromboembolism was significantly worse in the group of patients with preoperative high-risk factors than in those without them. However, 215 patients were in atrial fibrillation postoperatively, and in only 33 patients was it initially decided to administer coumadin permanently. This fact could be an additional reason for such a high incidence of thromboembolic events, since by changing the anticoagulation policy we significantly reduced the embolic complications.
Postoperative clinical results have been satisfactory, since 92.8% of the patients are in NYHA functional class I-II and leading an active normal life. Left ventricular and mitral valve functions also were satisfactory long-term after surgery. Significant residual mitral regurgitation was detected in only 1.2% of patients. Cardiac function and the incidence of mitral regurgitation compare favorably with the data reported for Carpentier rigid ring annuloplasty. 21 We conclude that mitral valve reconstructive surgery with Duran flexible ring annuloplasty for rheumatic disease can be carried out with very satisfactory early and long-term results, and it allows improvement of left ventricular function. These results also demonstrated the stability of this surgery, since only a reduced number of patients required reoperation for mitral structural deterioration.
